Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (81-90 of 282) with videos related to

Pageof 29
Sort By:
The Lancet. Rheumatology|January 26, 2024
Referring early arthritis patients within 6 weeks versus 12 weeks after symptom onset: an observational cohort studyEllis Niemantsverdriet, Maxime Dougados, Bernard Combe, et al.
The Journal of Rheumatology|July 15, 2003
Polymorphism of HLA-DMA and DMB alleles in patients with systemic lupus erythematosusJacques Morel, Clarisse Da Silva Simoes, Odile Avinens, et al.
Arthritis and Rheumatism|February 10, 2011
Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritisRachel Audo, Flavia Calmon-Hamaty, Dominique Baeten, et al.
Clinical and Experimental Rheumatology|May 13, 2010
Survey of the therapeutic management of rheumatoid arthritis in France: the OPALE studyAlain Saraux, Bernard Combe, Philippe Blin, et al.
Arthritis Care & Research|March 28, 2020
Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-AnalysisGuillaume Decarriere, Thomas Barnetche, Bernard Combe, et al.
Annals of the Rheumatic Diseases|October 4, 2017
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysisClaire Rempenault, Bernard Combe, Thomas Barnetche, et al.
RMD Open|January 31, 2024
Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory diseaseClaire Rempenault, Cédric Lukas, Léa Tardivon, et al.
Rheumatology (Oxford, England)|July 1, 2026
Stability and prognostic value of B-cell markers in primary Sjögren's syndrome: results from the French ASSESS cohortPaulina Szafors, Cedric Lukas, Bernard Combe, et al.
Arthritis Care & Research|January 11, 2019
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic ReviewClaire Rempenault, Bernard Combe, Thomas Barnetche, et al.
Arthritis Care & Research|December 21, 2018
Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta-AnalysisAurélie Beltai, Thomas Barnetche, Claire Daien, et al.
Pageof 29

Showing results (81-90 of 282) with videos related to

Sort By:
Pageof 29
The Lancet. Rheumatology|January 26, 2024
Referring early arthritis patients within 6 weeks versus 12 weeks after symptom onset: an observational cohort studyEllis Niemantsverdriet, Maxime Dougados, Bernard Combe, et al.
The Journal of Rheumatology|July 15, 2003
Polymorphism of HLA-DMA and DMB alleles in patients with systemic lupus erythematosusJacques Morel, Clarisse Da Silva Simoes, Odile Avinens, et al.
Arthritis and Rheumatism|February 10, 2011
Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritisRachel Audo, Flavia Calmon-Hamaty, Dominique Baeten, et al.
Clinical and Experimental Rheumatology|May 13, 2010
Survey of the therapeutic management of rheumatoid arthritis in France: the OPALE studyAlain Saraux, Bernard Combe, Philippe Blin, et al.
Arthritis Care & Research|March 28, 2020
Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-AnalysisGuillaume Decarriere, Thomas Barnetche, Bernard Combe, et al.
Annals of the Rheumatic Diseases|October 4, 2017
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysisClaire Rempenault, Bernard Combe, Thomas Barnetche, et al.
RMD Open|January 31, 2024
Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory diseaseClaire Rempenault, Cédric Lukas, Léa Tardivon, et al.
Rheumatology (Oxford, England)|July 1, 2026
Stability and prognostic value of B-cell markers in primary Sjögren's syndrome: results from the French ASSESS cohortPaulina Szafors, Cedric Lukas, Bernard Combe, et al.
Arthritis Care & Research|January 11, 2019
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic ReviewClaire Rempenault, Bernard Combe, Thomas Barnetche, et al.
Arthritis Care & Research|December 21, 2018
Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta-AnalysisAurélie Beltai, Thomas Barnetche, Claire Daien, et al.
Pageof 29